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Alzheimer disease (AD), a progressive neurodegenerative
disorder, is the most common type of dementia, occur-
ring in mid to late life. The neuropathological hallmarks
of this disease include the presence of extracellular de-
posits of highly fibrillogenic Ab42 peptides in senile
plaques and intraneuronal accumulations of hyper-
phosphorylated t in neurofibrillary tangles (see Giulian
1999 [in this issue]). Although most cases of AD occur
as age-associated disorders, autosomal dominant inher-
itance of mutant genes encoding the b-amyloid precursor
protein (APP), presenilin 1 (PS1), or presenilin 2 (PS2)
cause early-onset AD in several families (i.e., familial AD
[FAD]; for review, see Price and Sisodia 1998). In large
part, the clinical and neuropathological features of PS1-
linked AD are much more severe than those of sporadic
AD: the age at onset of disease can be as early as the
mid 20s, in some pedigrees, with more-rapid progression
than is typically seen in late-onset AD. Brains from in-
dividuals with PS1-linked FAD show severe Ab depo-
sition and neurofibrillary tangles (for review, see Price
and Sisodia 1998). Here we summarize genetic and de-
velopmental findings on the normal biology of presen-
ilin, as well as data from cell-culture and transgenic an-
imal experiments that probe the dysfunction of disease-
related presenilin variants.
Genetics of Presenilin-Linked Early-Onset AD
The families examined for identification of the locus
harboring PS1 were selected on the basis of the presence
of a family mean age at onset 52 years and clear au-
tosomal dominant inheritance of AD. The locus, called
“AD3,” was linked to a marker on 14q24.3 (Schellen-
berg et al. 1992; reviewed by Tanzi 1996). AD3 does
not appear to be subject to epistasis from other loci.
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Positional cloning defined a minimal cosegregating re-
gion in 21 pedigrees with autosomal dominant AD, and
Sherrington et al. (1995) isolated a novel cDNA that
corresponded to a sequence from this interval. The AD3-
linked disease gene, now called “presenilin-1” (PS1), en-
codes a protein of 467 amino acids, and Sherrington and
colleagues identified missense mutations in this gene that
cosegregate with FAD in five of these families. Subse-
quent database searches revealed a close homologue of
PS1, called “presenilin 2” (PS2), which maps to 1q31-
42, a region implicated in a large, well-characterized
FAD pedigree, the Volga Germans (VG). Missense mu-
tations in PS2 cosegregate with FAD in an unrelated
Italian FAD pedigree as well as in the VG group (Levy-
Lahad et al. 1995a, 1995b; Rogaev et al. 1995).
To date, 160 different mutations in PS1 or PS2 have
been described in 1100 families, of various ethnic origin,
with early-onset FAD (for review, see Tanzi et al. 1996)
More than 75% of the reported FAD mutations in PS1
occur in single kindreds, thus the characterization of
them as “private” mutations. With two notable excep-
tions, all presenilin mutations are missense substitutions.
However, in several unrelated pedigrees, intronic mu-
tations in PS1 lead to transcripts that lack exon 9
(DEx9), which encodes PS1 with an in-frame deletion of
29 amino acids and an amino acid substitution. Fur-
thermore, a single-nucleotide deletion at the consensus
splice-donor sequence in intron 4 has been observed in
two related individuals with autopsy-confirmed early-
onset AD. The mutant transcripts that result are pre-
dicted to encode prematurely truncated PS1 polypeptides
(reviewed by Price and Sisodia 1998).
Presenilin Structure and Metabolism
The topology of PS1 (and of its Caenorhabditis ele-
gans homologues, SEL-12 and HOP-1) has been deter-
mined with use of a variety of biochemical and cell-
biological approaches. These studies reveal that presen-
ilins span the membrane eight times, with exposure of
N- and C-termini and of a “loop” region between trans-
membrane helices 6 and 7 to the cytosol (Doan et al.
1996; Li and Greenwald 1996). PS1 and PS2 are not
substrates for sulfation, glycosylation, or acylation (re-
viewed by Selkoe 1998), but serine residues in the N-
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terminus and loop domains of PS1 and PS2 are phos-
phorylated in vivo. Although PS1 is synthesized as a
polypeptide with an apparent molecular weight of
∼42–43 kD, the preponderant PS1-related species that
accumulate in cultured mammalian cells, brain, and sys-
temic tissues are ∼30 kD N-terminal fragments (NTF)
and ∼20 kD C-terminal fragments (CTF) (reviewed by
Selkoe 1998). PS1 endoproteolysis occurs at amino acids
292 and 299 (Podlisny et al. 1997), and the FAD-as-
sociated PS1 variant, DEx9, which lacks amino acids
290–319, is not cleaved (Thinakaran et al. 1996).
Analysis of PS1 expression in transgenic mouse brain
and in cultured cells of neuronal and nonneuronal origin
indicates that the accumulation of PS1 fragments is
tightly regulated by associations with limiting cellular
components (Thinakaran et al. 1996). Thus, overex-
pression of PS1 or of PS2 leads to very minimal eleva-
tions in the levels of fragments, whereas the bulk of the
excess full-length PS1 and PS2 is rapidly degraded by
the proteosome (Kim et al. 1997; Podlisny et al. 1997).
Although the identity of the protease and the physio-
logical significance of PS1 proteolysis are not known,
the paucity of full-length PS1 and the tight regulation
of the stoichiometry and expression level of presenilin
fragments strongly suggest that the cleaved NTF and
CTF are the biologically active forms of the protein. Like
PS1, PS2, C. elegans, SEL-12, and Drosophila melano-
gaster presenilins are also subject to endoproteolytic
cleavage, which indicates that presenilin endoproteolysis
is a highly conserved process.
The observation that PS1 or PS2 fragments accumu-
late in 1:1 stoichiometry suggests that the NTF and CTF
may coassociate, perhaps in higher-order assemblies.
Two lines of evidence support this notion. First, frag-
ments derived from PS1 or PS2 can be specifically co-
immunoprecipitated from lysates of cultured cells or
mammalian brain (Thinakaran et al. 1998). PS1- and
PS2-derived fragments do not form mixed assemblies
and, although fragments derived from a chimeric PS1/
PS2 polypeptide can self-assemble, they do not interact
with fragments derived from wild-type PS1 or PS2
(Saura et al. 1999). Thus, presenilin assembly appears
to be tightly coupled with biosynthesis. Second, gel-
filtration chromatography and velocity gradient–
fractionation studies reveal that PS1, NTF, and CTF re-
main associated in large detergent-sensitive complexes
(reviewed by Selkoe 1998; Yu et al. 1998). The com-
ponents of the high-molecular-weight complexes are not
known, although several proteins that interact with var-
ious domains of PS1 or PS2 have been identified by use
of yeast two-hybrid assays. Among these putative pre-
senilin-interacting proteins are five armadillo-related
proteins: a-, b-, and g-catenin; p0071; and neural-spe-
cific plakophilin (Zhou et al. 1997; Yu et al. 1998; Stahl
1999). Notably, FAD-linked PS1 missense variants are
reported to destabilize and cause defective intracellular
trafficking of b-catenin (Zhang et al. 1998; Nishimura
et al. 1999). None of the identified interactors appears
to influence presenilin processing or accumulation of its
derivatives.
Function of Presenilins
The first major insight regarding presenilin function
emerged with the discovery of a homologous gene in C.
elegans, sel-12. sel-12 interacts with genes in the Notch-
signaling pathway, which has been widely studied for
clues to epithelial-cell determination and nervous sys-
tem–tissue development. Gain-of-function alleles of lin-
12 and glp-1, two C. elegans homologues ofNotch (Lev-
itan and Greenwald 1995), cause a multivulval pheno-
type, but this effect can be suppressed by mutations in
sel-12. In a wild-type background, mutant sel-12 alleles
cause a defect in egg laying. Because this phenotype is
rescued efficiently by transgenic expression of human
PS1 and PS2, it appears that the homologous proteins
can function interchangeably (Levitan et al. 1996; Bau-
meister et al. 1997). Human FAD-linked PS1 variants,
on the other hand, only partially rescue the egg-laying
defect (Levitan et al. 1996; Baumeister et al. 1997). A
second C. elegans protein, Hop-1, also rescues the egg-
laying defect of a sel-12 mutant (Li and Greenwald
1997), and reduction of hop-1 activity in a sel-12–de-
ficient strain reveals developmental phenotypes that are
similar to those of single and double mutants of lin-12
and glp-1. Because these phenotypes are not observed
in worms with single homozygous deletions of sel-12 or
of hop-1, it appears that the products of these genes are
functionally redundant (Li and Greenwald 1997; Wes-
tlund et al. 1999). Two models have been proposed to
account for the genetic interactions between the worm
presenilins (Sel-1 and Hop-1) and the Notch homo-
logues, particularly Lin-12. First, the presenilins could
regulate LIN-12 trafficking and cell-surface expression.
Alternatively, SEL-12 could act in a signaling capacity,
to modulate pathways activated after LIN-12 binding to
cognate ligands.
Despite the insights derived from the C. elegans ex-
periments, the biological functions of PS1 and PS2 in
mammals during development and aging are not fully
understood. The general spatial and temporal expression
patterns of presenilin mRNA during embryonic devel-
opment do not coincide directly with the expression pat-
terns of any specific member of the known mammalian
Notch homologues, suggesting either that PS1 functions
promiscuously or that its role is not limited to Notch
signaling (Lee et al. 1996). Mice with homozygous dis-
ruptions of PS1 die in late embryogenesis (Shen et al.
1997; Wong et al. 1997 ) and exhibit severe defects in
somite development and, subsequently, in the develop-
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Figure 1 Effects of PS1 deficiency on membrane protein traf-
ficking and cleavage. PS1-deficient neurons fail to cleave the amyloid-
precursor protein APP and to secrete the APP extracellular fragment,
Ab. This defect has been ascribed to the absence of so called g-secretase
activity, which perhaps is mediated directly by PS1. However, PS1-
deficient cells also secrete soluble APP derivatives at a faster rate,
suggesting that the trafficking of APP is altered. Recent studies indicate
that, in addition to APP, APLP1 and Notch1 are also cleaved ineffi-
ciently in PS1-deficient cells. Interestingly, the transmembrane domains
of APP, APLP1, and Notch1 (boxed) contain little sequence similarity.
In neurons lacking PS1, the maturation and the ligand-dependent au-
tophosphorylation activity of the receptor tyrosine kinase TrkB are
also severely compromised. Thus, it is likely that PS1 may influence
trafficking and metabolism of selected membrane proteins, including
APP, APLP1, Notch 1, and TrkB.
ment of the axial skeleton and ribs. The early somite
defect in PS1/ embryos is highly reminiscent of the
phenotype in mice lacking Notch1 or its ligand, Dll1,
although the latter animals die too early in development
for a skeletal phenotype to be manifest. Remarkably,
Notch1 and Dll1 mRNA expression is considerably re-
duced in the presomitic mesoderm of PS1/mice (Wong
et al. 1997). In addition, all the observed PS1/ embryos
exhibited intraparenchymal hemorrhages after day 11
of gestation, a phenotype shared with embryos lacking
Dll1. A series of transgenic rescue experiments have
shown that either wild-type or FAD-linked PS1 variants
can rescue Notch1 mRNA expression in the presomitic
mesoderm in early embryos and in the entire spectrum
of developmental deficits in PS1/ mice (reviewed by
Price and Sisodia 1998). Because the FAD-linked PS1
variants retain their normal function during mammalian
embryonic development, we argue that PS1-linked FAD
is not a haploinsufficiency condition but, rather, is due
to the mutant protein’s gain of function (see The Role
of Presenilin in Metabolism of APP and Notch). There
are no reports of mice lacking PS2, either alone or in
combination with PS1.
The Role of Presenilin in Metabolism of APP and
Notch
In both naive and stably transfected cells, PS1 is re-
stricted to the endoplasmic reticulum (reviewed by Sel-
koe 1998; S. H. Kim, G. Thinakaran, J. Lah, A. Levey,
S. S. Sisoda, unpublished data). Analyses done with cell
fractionation, light microscopy, and electronmicroscopy
show that the presenilins and their endoproteolytic de-
rivatives are associated predominantly with rough and
smooth endoplasmic reticulum (ER) elements and are
excluded from the Golgi apparatus and the ER-Golgi
intermediate compartment (Lah et al. 1997; Zhang et
al. 1998; S. H. Kim, G. Thinakaran, J. Lah, A. Levey,
S. S. Sisoda, unpublished data).
The most provocative insight pertaining to the mech-
anisms by which mutant PS1 predisposes carriers to FAD
emerged initially from studies of the biosynthesis and
maturation of APP. As depicted in figure 1, APP is subject
to cleavage at several sites. Ab peptides are liberated
from APP by the concerted action of two enzymatic ac-
tivities, b- and g-secretases. The b-secretase acts first, by
clipping the protein at a single site, releasing an extra-
cellular N-terminal domain and leaving a C-terminal
“stub” that encompasses 28 amino acids of the ecto-
domain, as well as the transmembrane (TM) and the
cytoplasmic domains. Two g-secretase sites are found 12
and 14 amino acids into the TM, and cleavage at these
sites releases Ab42 and Ab40, respectively. Both of these
products accumulate in the extracellular space, but Ab42
is particularly susceptible to fibril formation in vitro. As
discussed below, cleavage at both of these g-secretase
sites is strongly suppressed in animals that lack PS1 func-
tion, so the larger C-terminal APP stub accumulates in
PS1-deficient cells. However, the dominantly acting pre-
senilin mutations that are found in patients with FAD
have a different effect on this pathway. As Scheuner et
al. (1996) showed, affected individuals in kindreds with
PS1 or PS2 exhibit an elevated Ab42:Ab40 ratio in their
plasma, an effect that is also seen in conditionedmedium
from patients’ fibroblasts or from mammalian cells
transfected with mutant PS1 cDNA. The brains of trans-
genic mice expressing mutant PS1 show the same ele-
vation of Ab42 relative to Ab40 (reviewed by Price and
Sisodia 1998; Selkoe 1998).
Transgenic mice coexpressing FAD-linked PS1 vari-
ants and the Swedish APP FAD variant (APPSwe) exhibit
numerous amyloid deposits associated with dystrophic
neurites and reactive astrocytes, and these lesions appear
much earlier than those seen in mice expressing APPSwe
only (Borchelt et al. 1997; Holcomb et al. 1998). These
data demonstrate that the PS1 mutations act in synergy
with APPSwe, to accelerate the rate of amyloid deposition.
Similarly, immunocytochemical investigations of brains
of patients with PS1-linked FAD show significant in-
creases in Ab42 deposition, compared with brain tissue
from patients with sporadic AD (Lemere et al. 1996).
Collectively, these findings suggest that mutations in PS1
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cause disease primarily by elevating extracellular con-
centrations of Ab42 to promote amyloid deposition.
The mechanisms by which mutant presenilin influ-
ences production of Ab42 peptides are not known.How-
ever, reports that full-length PS1 and PS2 form stable
heteromeric assemblies with APP in culturedmammalian
cells suggest that mutant PS1 facilitates cleavage by the
activity of an ill-defined proteolytic enzyme, described
as a g-secretase (Weidemann et al. 1997; Xia et al. 1997).
On the other hand, we and others have failed to detect
any interaction between the presenilins and APP (Thi-
nakaran et al. 1998; Ray et al. 1999). The latter findings,
together with the nonoverlapping subcellular distribu-
tions of the presenilins in the ER and in the endosomal/
plasma membrane sites where Ab peptides are generated,
argue against a direct role of PS1 or PS2 in the cleavage
of APP.
In this regard, the recent observation that neurons
from PS1 knockout mice fail to secrete Ab peptides
(DeStrooper et al. 1998; Naruse et al. 1998) might sup-
port the view that PS1 itself acts as a g-secretase. Studies
done by Selkoe and colleagues show substantial reduc-
tions in Ab secretion and increased accumulation of cy-
toplasmic APP fragments in Chinese-hamster-ovary cells
that express variants of PS1 harboring artificial muta-
tions of aspartate residues in transmembrane domains
6 and 7 (Wolfe et al. 1999). Interestingly, these mutant
PS1 molecules are not subject to endoproteolysis, and
the suggestion that PS1 contains an intrinsic proteolytic
activity may support the view that PS1 acts directly on
APP, as a g-secretase (Wolfe et al. 1999). It will be critical
for investigators to test this model by reconstituting these
proteolytic activities with purified components.
Regardless of the outcome of such studies, PS1
deficiency clearly affects the proteolytic activation of
Notch1. In PS1-deficient immortalized fibroblasts, a con-
stitutively active Notch1 variant is clipped from its
membrane domain only inefficiently and it fails to be
released from the plasma membrane or to accumulate
in the nucleus, where it would otherwise activate the
transcription of target genes (DeStrooper et al. 1999).
Since these conclusions were derived from analysis of a
constitutively active form of Notch1, it will be of interest
to evaluate the role of PS1 in the proteolysis and bio-
logical activity of wild-type Notch, in both the absence
and presence of ligand. In this regard, Struhl and Green-
wald (1999) demonstrated that null mutations in the D.
presenilin gene lead to extensive neuronal hyperplasia
and deformed wing phenotypes, similar to those ob-
served in Notch flies; these authors found that, in the
absence of presenilin, ligand-dependent Notch-signal
transduction is abolished, and the cytosolic domain, de-
rived from transmembrane forms of Notch, fails to enter
the nucleus. Nuclear import of a constitutively active
cytosolic form of Notch is normal in these flies, sug-
gesting that the loss of Notch proteolysis in presenilin
flies accounts for their signaling failure and for the con-
sequent developmental abnormalities. However, Ye et al.
(1999) also studied Drosophila with loss-of-function al-
leles of presenilin and, although they confirm the neu-
rogenesis defects in these strains, their work leads to
different conclusions about the role of proteolysis. In
contrast to the observations by Struhl and Greenwald
(1999), Ye et al. (1999) observe that presenilinmutations
block signals mediated by either the membrane-tethered
or the cytosolic forms of Notch1, indicating that pre-
senilin acts elsewhere in the Notch pathway to permit
normal neuronal and wing-disk development. To date,
there is no explanation for these divergent findings; but,
in view of differences in the chimeric Notch reporters
used in these studies, it is plausible that these molecules
are differentially sensitive to loss of presenilin function.
Although there are obvious parallels between the pro-
teolysis of APP and Notch1, we find it inconceivable
that PS1 is the endoprotease involved in intramembrane
cleavage of each substrate. There is little, if any, ho-
mology between the Notch1 and APP transmembrane
domains, and the positions of the scissile bonds, with
respect to the boundaries of each transmembrane helix,
are quite different (see fig. 1). Furthermore, we recently
demonstrated that a C-terminal portion of the APP ho-
mologue APLP1 also accumulates in PS1/ neurons
(Naruse et al. 1998). Because the APP and APLP1 trans-
membrane domains also have very limited homology
(fig. 1), we favor the alternative hypothesis—that ER-
associated PS1 indirectly influences the endoproteolysis
of APP, APLP1, and Notch1 by altering trafficking and
cocompartmentalization of these proteins with specific
proteases that act later in the secretory pathway. In this
regard, the maturation of other integral membrane gly-
coproteins, such as the receptor tyrosine kinase TrkB,
are also impaired in PS1-deficient neurons (Naruse et al.
1998). In C. elegans, as well, reduced Sel-12 activity
appears to perturb development by altering the locali-
zation of critical signaling molecules. Thus, vulval pre-
cursor cells in mutant animals express abnormally low
levels of Lin-12 protein on their apical membrane (Lev-
itan and Greenwald 1998). Because Sel-12 is localized
primarily to the ER or Golgi in nematode cells, it appears
that one widely conserved function of the presenilins
may be the control of intracellular transport of Notch
homologues.
Conclusions and Future Directions
The discovery that mutations in genes encoding PS1
and PS2 are linked to FAD has ushered in a new and
extremely exciting era of research, aimed at clarifying
the cellular and molecular biology of the presenilin poly-
peptides and the relationships of the genetic variants to
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the pathogenesis of AD. Neither the manner in which
the presenilin derivatives assemble in the lipid bilayer
nor the nature of the apparatus responsible for endo-
proteolysis and regulation of presenilin localization and
stability is known. Equally intriguing are the mecha-
nisms by which FAD-linked mutant PS1 causes selective
increases in the production of highly fibrillogenic Ab42
peptides and accelerates Ab deposition in brains of trans-
genic mice. The surprising discovery that loss of PS1
function abrogates Ab production and causes the C-ter-
minal stub of APP to accumulate in cells has led to the
suggestion that PS1 acts as a g-secretase. However, be-
cause multiple structurally unrelated membrane proteins
are abnormally distributed and incorrectly processed in
cells that lack PS1, we favor the view that presenilins
act indirectly in the processing of APP, by promoting the
colocalization of APP with some specific proteinase.
Although the importance of the role of PS1 in the
regulation of somitogenesis is now established, the
mechanisms by which PS1 facilitates Notch processing
and signaling in mammalian cells, Drosophila, and C.
elegans are just beginning to emerge. Despitewidespread
interest in the significance of presenilins to aging, no
postembryonic functions of PS1 have been defined. Fu-
ture efforts directed at generation of transgenic animals
in which PS1 genes can be conditionally ablated in a
temporal and/or tissue-specific manner will be necessary
in order to address this important issue.
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